Akebia Therapeutics Inc (AKBA): The Latest Casualty Of Increased Volatility?
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 2.16M shares in volume on a normal day but saw 3982767 shares change hands in the recent trading day. The company now has a market cap of 392.73M USD. Its current market price is $1.80, marking a decrease of -5.76% compared to the previous close of $1.91. The 52 […]
Investors Are Waking Up To Akebia Therapeutics Inc (NASDAQ: AKBA) After Rising 34.69% Over The Past 12 Months
Akebia Therapeutics Inc (NASDAQ:AKBA) currently has a daily average trading volume of 2.13M but it saw 1646173 shares traded in last market. With a market cap of 432.00M USD, the company’s current market price of $1.98 came falling about -4.35 while comparing to the previous closing price of $2.07. In past 52 weeks, the stock […]
Akebia Therapeutics Inc (AKBA): Investing In A Time Of Crisis
Akebia Therapeutics Inc (NASDAQ:AKBA) currently has a daily average trading volume of 2.17M but it saw 1271272 shares traded in last market. With a market cap of 460.36M USD, the company’s current market price of $2.11 came rising about 0.48 while comparing to the previous closing price of $2.10. In past 52 weeks, the stock […]
Do Analysts Think Akebia Therapeutics Inc (AKBA) Is Still Worth Buying In 2025?
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 2.26M shares in volume on a normal day but saw 1435867 shares change hands in the recent trading day. The company now has a market cap of 466.91M USD. Its current market price is $2.14, marking a decrease of -0.93% compared to the previous close of $2.16. The 52 […]
Should Investors Trust The Upside Potential In Akebia Therapeutics Inc (AKBA)?
Akebia Therapeutics Inc (NASDAQ:AKBA) currently has a daily average trading volume of 2.34M but it saw 1095286 shares traded in last market. With a market cap of 473.46M USD, the company’s current market price of $2.17 came rising about 1.40 while comparing to the previous closing price of $2.14. In past 52 weeks, the stock […]
Do Analysts Think Akebia Therapeutics Inc (AKBA) Is Still Worth Buying In 2025?
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 2.35M shares in volume on a normal day but saw 1851711 shares change hands in the recent trading day. The company now has a market cap of 488.73M USD. Its current market price is $2.24, marking a decrease of -2.61% compared to the previous close of $2.30. The 52 […]
